Business

Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health

Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a significant step in Yuyu Pharma's plan to become a more active global player in the fast-growing animal health sector.

articleYuyu Pharma, Inc.December 2, 20252/company/yuyu-pharma/news/yuyu-pharma-announces-strategic-investment-140000261
Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health

About this update from Yuyu Pharma, Inc.

[{"type":"text","content":"SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a significant step in Yuyu Pharma's plan to become a more active global player in the fast-growing animal health sector.","length":420,"tagName":"p"},{"type":"image","alt":"Logo of Yuyu Pharma","displaySize":"","headline":null,"caption":"Logo of Yuyu Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":136,"url":"https://media.zenfs.com/en/prnewswire.com/7cd70ca77e995c08b0c7aa0def1d256d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/S9JQLcfP7gskjBsQJc7duw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI0MDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/7cd70ca77e995c08b0c7aa0def1d256d","width":400,"height":136}},"href":"https://mma.prnewswire.com/media/2835911/CI_2019_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Dalan is recognized for delivering the world's first USDA-approved honeybee vaccine and is now advancing a first-in-class shrimp vaccine aimed at transforming disease management in global aquaculture. This investment will allow Dalan to continue to expand its platform across new species, exploring novel applications for poultry, and other aquaculture species where its technology has the potential to enable broad-spectrum disease prevention and reduce dependence on antibiotics. Yuyu Pharma views these areas as strategically important for the future of global health and agriculture.","length":596,"tagName":"p"},{"type":"text","content":""Yuyu Pharma is moving decisively into new areas of animal health where scientific innovation can create lasting global impact," said Robert Wonsang Yu, Chief Executive Officer of Yuyu Pharma. "Bees, shrimp, and other essential species play foundational roles in food systems and environmental stability. Our investment in Dalan reflects a clear ambition: to engage directly with technologies that will shape the next generation of global animal health solutions."","length":484,"tagName":"p"},{"type":"text","content":"Yuyu Pharma is also extending its reach within companion animal innovation. The compan...

More updates from Yuyu Pharma, Inc.

Animal Healthstrategic investmentsRobert Wonsang YuPharmaDalan